lawsone has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bruyère, C; Epifano, F; Fiorito, S; Genovese, S; Kiss, R; Mathieu, V | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Barati Naeeni, N; Ghafaripour, H; Homayouni Tabrizi, M; Karimi, E | 1 |
| Batista, AA; Cominetti, MR; Corrêa, RS; Deflon, VM; Liany, LD; Oliveira, KM | 1 |
| Almeida, RG; Baiju, TV; Brito, LM; Cavalcanti, BC; da Silva Júnior, EN; de Simone, CA; Namboothiri, INN; Pessoa, C; Sivanandan, ST | 1 |
| Barani, M; Mirzaei, M; Nematollahi, MH; Torkzadeh-Mahani, M | 1 |
| Schulz, C | 1 |
| Guzin, G; Yucel, I | 1 |
2 review(s) available for lawsone and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
[Report on the 67th and 68th of the provisional Commission for Cosmetic Medication of the Federal Institute for Risk Assessment (BfR) from 3 and 4 December 2003 and 6 May 2004 in Berlin].
Topics: Animals; Cosmetics; Female; Germany; Government Agencies; Hair Color; Hair Dyes; Humans; Male; Naphthoquinones; Neoplasms; Radiation Injuries; Risk Assessment; Risk Factors; Sunscreening Agents; Tattooing; Vitamin A; Zinc Oxide | 2004 |
6 other study(ies) available for lawsone and Neoplasms
| Article | Year |
|---|---|
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colorimetry; Growth Inhibitors; Humans; Naphthoquinones; Neoplasms; Plant Extracts | 2014 |
Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Chitosan; Drug Carriers; Folic Acid; Glycols; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; G1 Phase; Humans; Naphthoquinones; Neoplasms; Ruthenium; S Phase | 2017 |
Quinonoid compounds via reactions of lawsone and 2-aminonaphthoquinone with α-bromonitroalkenes and nitroallylic acetates: Structural diversity by C-ring modification and cytotoxic evaluation against cancer cells.
Topics: Acetates; Alkenes; Amination; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Furans; Halogenation; Humans; Models, Molecular; Naphthoquinones; Neoplasms; Pyrroles; Quinones; Structure-Activity Relationship | 2018 |
Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.
Topics: Cell Line, Tumor; Cell Survival; Cholesterol; Drug Compounding; Drug Liberation; Drug Stability; Humans; Lawsonia Plant; Liposomes; Naphthoquinones; Neoplasms; Particle Size; Plant Extracts; Surface Properties; Surface-Active Agents | 2018 |
Topical henna for capecitabine induced hand-foot syndrome.
Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Naphthoquinones; Neoplasms; Paresthesia; Severity of Illness Index; Syndrome; Treatment Outcome | 2008 |